Search results for "Cardiovascular Disease"
Updated guideline on cholesterol management focuses on detailed risk assessment
The guideline from the American College of Cardiology/American Heart Association recommends that physicians talk to patients about risk-enhancing factors that can help provide a more personalized risk assessment, in addition to such traditional risk factors as smoking and high blood pressure.
https://immattersacp.org/weekly/archives/2018/11/20/2.htm
20 Nov 2018
No association between antihypertensive treatment and mortality, CVD in mild, low-risk hypertension, but some association with increased adverse events
Physicians following guidelines that generalize findings from hypertension trials conducted in high-risk individuals to those at lower risk should use caution, the study authors noted.
https://immattersacp.org/weekly/archives/2018/11/06/5.htm
6 Nov 2018
Cardiovascular safety of febuxostat and allopurinol compared in patients with gout and CVD
In a modified intention-to-treat analysis, the primary end point of first occurrence of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or urgent revascularization for unstable angina occurred in 10.8% of patients taking febuxostat and in 10.4% of patients taking allopurinol (hazard ratio, 1.03).
https://immattersacp.org/weekly/archives/2018/03/20/4.htm
20 Mar 2018
Exercise a fitting path to improved health
Some physicians tout successes in getting patients moving more by suggesting incremental changes in their activity levels, and also by highlighting the more immediately visible payoffs.
https://immattersacp.org/archives/2021/04/exercise-a-fitting-path-to-improved-health.htm
1 Apr 2021
Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD
An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2019/07/16/2.htm
16 Jul 2019
Discussing lifetime vs. 10-year CVD risk estimates led to higher patient risk perception, willingness for therapy
Patients who were presented with cardiovascular disease (CVD) risk information using a pictogram had lower perception of risk and were less willing to consider therapy than those presented with a bar graph or no graphic at all.
https://immattersacp.org/weekly/archives/2018/11/13/1.htm
13 Nov 2018
Weighing benefits, harms of cannabis
Marijuana use has risen, so internists need to understand its real risks as well as its potential clinical uses, such as for chronic pain, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity symptoms.
https://immattersacp.org/archives/2019/04/weighing-benefits-harms-of-cannabis.htm
1 Apr 2019
Fasting may not be necessary before lipids testing, study finds
In this post hoc follow-up analysis of a randomized clinical trial, triglyceride levels were slightly higher in nonfasting samples than fasting samples, and cholesterol levels in both types of samples were similar.
https://immattersacp.org/weekly/archives/2019/06/04/4.htm
4 Jun 2019
AHA releases scientific statement on cardiovascular health in African-American patients
Obesity, hypertension, and diabetes generally occur earlier in African-American patients than in white patients, and adverse health behaviors may partly explain the higher burden of risk factors for cardiovascular disease.
https://immattersacp.org/weekly/archives/2017/10/31/4.htm
31 Oct 2017
Oral fluoroquinolones may not be associated with increased arrhythmia risk
Researchers detected a significant difference according to age group, but no statistically significant differences in rate ratios in subanalyses of underlying cardiovascular disease, co-treatment with drugs known to increase the risk of torsades de points, country of residence, or sex or across levels of arrhythmia risk score.
https://immattersacp.org/weekly/archives/2016/03/08/5.htm
8 Mar 2016